top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Translational Development Acquisition Corp. - Ordinary Shares (NQ:TDAC)

10.87 +0.01 (+0.09%)
Streaming Delayed Price Updated: 3:34 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,661
Open 10.86
Bid (Size) 10.80 (3,400)
Ask (Size) 11.44 (300)
Prev. Close 10.86
Today's Range 10.86 - 10.88
52wk Range 10.34 - 10.95
Shares Outstanding 5,139,652
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium’s latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
Appointment intended to strengthen commercialization, scaling and cross-border governance capabilities as ProLogium prepares for its next stage of global growth 
From ProLogium Technology Co., Ltd.
Via GlobeNewswire

Performance

YTD
+3.8%
+3.8%
1 Month
+0.5%
+0.5%
3 Month
+1.7%
+1.7%
6 Month
+2.7%
+2.7%
1 Year
+5.0%
+5.0%

More News

Read More
News headline image
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
From ProLogium Technology Co., Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is Translational Development Acquisition Corp. - Ordinary Shares publicly traded?
Yes, Translational Development Acquisition Corp. - Ordinary Shares is publicly traded.
What exchange does Translational Development Acquisition Corp. - Ordinary Shares trade on?
Translational Development Acquisition Corp. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Translational Development Acquisition Corp. - Ordinary Shares?
The ticker symbol for Translational Development Acquisition Corp. - Ordinary Shares is TDAC on the Nasdaq Stock Market
What is the current price of Translational Development Acquisition Corp. - Ordinary Shares?
The current price of Translational Development Acquisition Corp. - Ordinary Shares is 10.87
When was Translational Development Acquisition Corp. - Ordinary Shares last traded?
The last trade of Translational Development Acquisition Corp. - Ordinary Shares was at 09/25/26 03:34 PM ET
What is the market capitalization of Translational Development Acquisition Corp. - Ordinary Shares?
The market capitalization of Translational Development Acquisition Corp. - Ordinary Shares is 55.87M
How many shares of Translational Development Acquisition Corp. - Ordinary Shares are outstanding?
Translational Development Acquisition Corp. - Ordinary Shares has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page